These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1838765)

  • 1. Left ventricular hypertrophy as a risk factor: the Framingham experience.
    Kannel WB
    J Hypertens Suppl; 1991 Dec; 9(2):S3-8; discussion S8-9. PubMed ID: 1838765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension, hypertrophy, and the occurrence of cardiovascular disease.
    Kannel WB
    Am J Med Sci; 1991 Oct; 302(4):199-204. PubMed ID: 1833977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study.
    Kannel WB; Levy D; Cupples LA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S135-40. PubMed ID: 2485019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham Study.
    Kannel WB; Abbott RD
    Am Heart J; 1986 Feb; 111(2):391-7. PubMed ID: 2936230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular hypertrophy as a risk factor in arterial hypertension.
    Kannel WB
    Eur Heart J; 1992 Sep; 13 Suppl D():82-8. PubMed ID: 1396865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic implications of left ventricular hypertrophy in arterial hypertension].
    Kannel WB
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():11-21. PubMed ID: 2150470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study.
    Levy D
    Drugs; 1988; 35 Suppl 5():1-5. PubMed ID: 2975214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and natural history of electrocardiographic left ventricular hypertrophy.
    Kannel WB
    Am J Med; 1983 Sep; 75(3A):4-11. PubMed ID: 6226193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy and mortality--results from the Framingham Study.
    Kannel WB; Cobb J
    Cardiology; 1992; 81(4-5):291-8. PubMed ID: 1301257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
    J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and epidemiology of heart failure.
    Kannel WB
    Heart Fail Rev; 2000 Jun; 5(2):167-73. PubMed ID: 16228142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of left ventricular hypertrophy: insights from the Framingham Study.
    Levy D
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S1-6. PubMed ID: 1715449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and ECG left ventricular hypertrophy.
    Muiesan ML; Salvetti M; Di Castelnuovo A; Paini A; Assanelli D; Costanzo S; Badilini F; Vaglio M; Donati MB; Agabiti Rosei E; de Gaetano G; Iacoviello L;
    J Hypertens; 2017 Jan; 35(1):162-169. PubMed ID: 27662187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy on electrocardiogram: prognostic implications from a 10-year cohort study of older subjects: a report from the Bronx Longitudinal Aging Study.
    Kahn S; Frishman WH; Weissman S; Ooi WL; Aronson M
    J Am Geriatr Soc; 1996 May; 44(5):524-9. PubMed ID: 8617900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?
    Antikainen RL; Grodzicki T; Palmer AJ; Beevers DG; Webster J; Bulpitt CJ;
    J Hum Hypertens; 2006 Jun; 20(6):451-9. PubMed ID: 16708082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
    van Kleef MEAM; Visseren FLJ; Vernooij JWP; Nathoe HM; Cramer MM; Bemelmans RHH; van der Graaf Y; Spiering W;
    J Hypertens; 2018 Sep; 36(9):1865-1873. PubMed ID: 29878973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertensive concentric left ventricular hypertrophy: when is ventricular ectopic activity increased?
    Lavie CJ; Nunez BD; Garavaglia GE; Messerli FH
    South Med J; 1988 Jun; 81(6):696-700. PubMed ID: 2967546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and natural history of left ventricular hypertrophy in hypertension.
    Borhani NO
    J Clin Hypertens; 1987 Mar; 3(1):104-11. PubMed ID: 2952766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension.
    Verdecchia P; Porcellati C; Reboldi G; Gattobigio R; Borgioni C; Pearson TA; Ambrosio G
    Circulation; 2001 Oct; 104(17):2039-44. PubMed ID: 11673343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.